MDRX Veradigm Inc

2bPrecise LLC, a wholly owned subsidiary of Allscripts Healthcare Inc. (Allscripts) (NASDAQ:MDRX), has launched a strategic early adopter program at the National Institutes of Health (NIH), America’s leading Care Institution for clinical research and a long-time Allscripts Sunrise™ client. The program will focus on deploying a cloud-based genomics and precision medicine solution designed by 2bPrecise.

The 2bPrecise EHR Agnostic solution will enable physicians and researchers to use genomic information in their current Allscripts Sunrise™ workflow, simplifying and optimizing the complex process of finding, selecting, ordering and receiving genomic tests. Using the 2bPrecise genomics and precision medicine solution, results of genomic sequencing tests will be made available and actionable at the point of care through Allscripts Sunrise™ electronic health record (EHR).

Experts from NIH in the field of genomic medicine will be the early adopters of the 2bPrecise solution. Users of the program will pan across the National Human Genome Research Institute, the National Cancer Institute and the NIH Clinical Center.

“We are honored and excited to work with NIH, one of the most innovative research institutions in the world, on this dimensional change of health care.  2bPrecise will soon be able to take a big step toward bringing an easy-to-use, clinical-genomic solution into the mainstream,” said 2bPrecise General Manager Assaf Halevy. Soon, this solution offering will be available to any provider, integrated delivery network or payer organization who wants to advance the research that will unlock new insights of molecular diagnostics and new treatments.

In addition to improving the workflow experience for physicians and nurses, the 2bPrecise solution uses advanced methods in clinical-genomic ontology and data harmonization and will return merged, semantically harmonized knowledge in a machine-readable and structured format. Medical researchers can combine genomic data with clinical and environmental information in a manner that enables statistical analysis and pattern detection.

About the National Institutes of Health (NIH)

NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

About 2bPrecise

A fully owned subsidiary of Allscripts, 2bPrecise addresses the challenge of enabling clinical utilization of ‘precision medicine’ data by delivering actionable, interpreted, and patient-specific information in a readable and computable format within a provider’s existing clinical workflow, truly facilitating decision-making at the point of care.

The cloud-based precision-medicine platform harmonizes genomic, clinical, and lifestyle data and brings precise, EMR-agnostic, in-workflow interventions that work seamlessly within existing provider workflow. Learn more at www.2bPrecisehealth.com.

About Allscripts

Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2016 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

2bPrecise, the 2bPrecise logo, and other 2bPrecise marks are trademarks of 2bPrecise, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of 2bPrecise, LLC and/or its affiliates.

For more information, contact:
Investors:
Seth Frank
312-506-1213
seth.frank@allscripts.com 

Media: 
Concetta DiFranco
312-447-2466
concetta.difranco@allscripts.com